Skip to content

Liver parenchyma transection-first approach in laparoscopic anatomical right hemihepatectomy: a retrospective cohort study

A new strategy of laparoscopic anatomical right hemihepatectomy via a hepatic parenchymal transection-first approach guided by the middle hepatic vein

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086625
Enrollment
Unknown
Registered
2024-07-08
Start date
2024-07-10
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC

Interventions

hepatic parenchymal transection-first approach:NA
extrahepatic Glissonian approach:NA

Sponsors

Department of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University, Chongqing 400037, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) From January 2017 to December 2022, he received laparoscopic right hemihepatectomy in the Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Army Military Medical University; (2) Hepatocellular carcinoma was confirmed by postoperative pathology; (3) No adjacent organ invasion and distant metastasis; (4) No tumors of other systems were present before surgery.

Exclusion criteria

Exclusion criteria: (1) Repeated hepatectomy for recurrent HCC; (2) hepatectomy combined with other operations; (3) Received other antitumor therapy before surgery; (4) Lack of clinical data.

Design outcomes

Primary

MeasureTime frame
operation time;

Secondary

MeasureTime frame
intraoperative blood loss;Short-term postoperative complications;overall survival;recurrence-free survival;

Countries

China

Contacts

Public ContactLu Zheng

Department of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University

xqyyzl1@163.com+86 136 2972 0282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026